This research aimed to determine the synergistic antitumor activity of ETO and CBD in an in vitro model of GBM cell lines, and to develop PLGA-based NPs, enabling the effective incorporation of both of these substances into the polymeric matrix. This evidence concerns the gene RUNX1T1 and glioblastoma.